 Home > Active Ingredient News > Endocrine System > JAHA: The relationship between non-alcoholic fatty liver and heart failure risk

JAHA: The relationship between non-alcoholic fatty liver and heart failure risk

 Last Update: 2021-12-03
 Source: Internet
 Author: User

Tags

classification bone diseases

mycobacterium tuberculosis disease

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Non-alcoholic fatty liver disease (NAFLD) includes liver steatosis, non-alcoholic steatohepatitis, and non-alcoholic steatohepatitis-related cirrhosis .

Non-alcoholic fatty liver disease (NAFLD) includes liver steatosis, non-alcoholic steatohepatitis, and non-alcoholic steatohepatitis-related cirrhosis.

Recently, the heart blood vessels published a research article on the disease areas authoritative magazine JAHA, this is a retrospective cohort study conducted for Medicare beneficiaries

Heart vascular diagnosis

During the follow-up period (October 2015 to December 2016), researchers used at least 1 hospitalization or at least 2 outpatient HF claims to define HF events

Among the 870,535 medical insurance beneficiaries, 3.

diabetes

It can be seen that NAFLD patients have an increased risk of HF.

NAFLD patients have an increased risk of HF.

Original source:

Marat Fudim,et al.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

USP Factory Direct Purity Degree 99% Progesterone

CAS No.: 57-83-0

Pharmacy Grade

$180-230/KG FOB

15-EPI CLOPROSTENOL

CAS No.: 55028-72-3

$1/KG EXW

Acetyl Dipeptide-1 cetyl ester

CAS No.: 196604-48-5

$1/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.